Michael Charles Ryan - 01 Jul 2021 Form 3 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Chief Technology Officer
Signature
/s/ Michael Charles Ryan
Issuer symbol
KRBPQ
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
3
Filing time
27 Jul 2021, 13:28:33 UTC
Next filing
02 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KRBP Stock Options 01 Jul 2021 Common Stock 2,863 $17.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest (that is, become exercisable) with respect to the shares as follows: This option will vest with respect to 1,433 Shares on December 7, 2019 and the remainder will vest at an annual rate of 715 shares per year for the next 2 years.